Appropriate antimicrobial treatment in nosocomial infections - the clinical challanges

被引:45
作者
Masterton, R [1 ]
Drusano, G
Paterson, DL
Park, G
机构
[1] Crosshouse Hosp, Ayrshire & Arran Acute Hosp NHS Trust, Kilmarnock KA2 0BE, Scotland
[2] Albany Med Ctr, Clin Res Inst, Div Clin Pharmacol, Albany, NY USA
[3] Univ Pittsburgh, Ctr Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA
[4] Addenbrookes Hosp, Intens Care Unit, Cambridge, England
关键词
antibiotics; nosocomial infections; outcomes; drug therapy;
D O I
10.1016/S0195-6701(03)00294-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Resistance to antimicrobial agents is emerging in a wide variety of pathogens, particularly those that cause nosocomial infections. As a consequence of this increasing resistance, morbidity and mortality in nosocomial infections is also increasing. It is therefore critical to treat nosocomial infections appropriately by starting antimicrobial treatment early in the course of infection, using the correct agent, at the most appropriate dose, and for an adequate duration. Indeed early 'appropriate' antibiotic prescribing has been shown significantly to reduce mortality, Length of intensive care unit and hospital stay and overall costs. Early use of the correct antibiotic at the appropriate dose and for an adequate duration are key to initial appropriate antibiotic prescribing. Choosing the right antibiotic depends mainly on the likely pathogen(s) and the expected local susceptibility patterns. Selection of appropriate antimicrobial therapy requires a thorough understanding of the likely microbial cause of the infection, including local susceptibility patterns, as well as the properties of the antimicrobials available for treating these infections, namely spectrum of activity and potency (including activity versus known resistance mechanisms), pharmacokinetic profile and tolerability and safety. This review, based on a series of presentations at the 5th International Conference of the Hospital Infection Society (Edinburgh, 2002) examines the importance of appropriate antimicrobial therapy in nosocomial infections, and provides guidance on how to achieve this. (C) 2003 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
[1]  
Alvarez-Lerma F, 2001, DRUGS, V61, P763
[2]   Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit [J].
AlvarezLerma, F ;
Pellus, AM ;
Sanchez, BA ;
Ortiz, EP ;
Jorda, R ;
Barcenilla, F ;
Maravi, E ;
Galvan, B ;
Palomar, M ;
Serra, J ;
Bermejo, B ;
Mateu, A ;
Quintana, E ;
Palacios, MS ;
Giral, R ;
Gonzalez, V ;
Lerma, FA ;
Mesa, JL ;
Melgarejo, JA ;
Martinez, J ;
Insausti, J ;
Olaechea, P ;
Chanovas, M ;
Gilabert, A ;
Junquera, C ;
Valles, J ;
Palacios, F ;
Calvo, R ;
Mesalles, E ;
Nava, J ;
Santos, A ;
Armengol, S ;
Marzo, D .
INTENSIVE CARE MEDICINE, 1996, 22 (05) :387-394
[3]   Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia - Link between quality of care and resource utilization [J].
Battleman, DS ;
Callahan, M ;
Thaler, HT .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (06) :682-688
[4]   Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance [J].
Burgess, DS .
CHEST, 1999, 115 (03) :19S-23S
[5]   Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa [J].
Carmeli, Y ;
Troillet, N ;
Karchmer, AW ;
Samore, MH .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1127-1132
[6]  
COLARDYN F, 1996, CLIN INTENSIVE CA S6, V7, P19
[7]   INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J].
CRAIG, WA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) :89-96
[8]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[9]   The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J].
DiGiovine, B ;
Chenoweth, C ;
Watts, C ;
Higgins, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :976-981
[10]  
Drusano GL, 1997, J CHEMOTHERAPY, V9, P38